Log in to save to my catalogue

The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial...

The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2162948869

The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway

About this item

Full title

The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway

Publisher

Athens: Spandidos Publications

Journal title

International journal of oncology, 2019-02, Vol.54 (2), p.753

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications

More information

Scope and Contents

Contents

The mutation of isocitrate dehydrogenase (IDH)1 (R132H) and IDH2 (R172K) and the induction of hypoxia in various solid tumors results in alterations in metabolic profiles, including the production of the D- or l-forms of 2-hydroxyglutarate (2HG) from [alpha]-ketoglutarate in aerobic metabolism in the tricarboxylic acid (TCA) cycle. However, it is u...

Alternative Titles

Full title

The oncometabolite d‑2‑hydroxyglutarate induces angiogenic activity through the vascular endothelial growth factor receptor 2 signaling pathway

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2162948869

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2162948869

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2018.4649

How to access this item